Evidence map›Paper›PMID 28523610›Full record

ArticleAging clinical and experimental research2018

Motivators for Alzheimer's disease clinical trial participation.

Shoshana H Bardach, Sarah D Holmes, Gregory A Jicha

Open access · greenAbstract read
In one paragraph

Article in Aging clinical and experimental research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Research satisfaction among participants in a preclinical Alzheimer's disease trial.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Experiences of Participation in a Multimodal Preventive Trial MIND-ADJournal of multidisciplinary healthcare · 2022
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Shoshana H BardachGraduate Center for Gerontology, College of Public Health, University of Kentucky, Lexington, KY, USA. shbardach@uky.edu.
Sarah D HolmesUniversity of Maryland, Baltimore, MD, USA.
Gregory A JichaSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
University of Kentucky · USUniversity of Maryland, Baltimore · US

Funding

University of Kentucky Alzheimer's Disease Core Center - Biomarker CoreP30AG028383 · NIA · UNIVERSITY OF KENTUCKY · PI GOLD, BRIAN TIMOTHY, VAN ELDIK, LINDA J · 2006 to 2020
$23.3M
INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression: The INCREASE studyR01AG054130 · NIA · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, MOGA, DANIELA CLAUDIA · 2016 to 2020
$2.0M
Early Detection and Prevention of Mild Cognitive Impairment due to Cerebrovascular DiseaseR01NR014189 · NINR · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, MOSER, DEBRA KAY · 2012 to 2016
$2.0M
Modulation of microRNA pathways by gemfibrozil in predementia Alzheimer diseaseR01AG042419 · NIA · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, NELSON, PETER T. · 2013 to 2016
$1.6M
NIA NIH HHS P30 AG028383NIA NIH HHS R01 AG042419NIA NIH HHS R01 AG054130NINR NIH HHS R01 NR014189
6 · The paper itself

Abstract

backgroundAlzheimer's disease (AD) research progress is impeded due to participant recruitment challenges. This study seeks to better understand, from the perspective of individuals engaged in clinical trials (CTs), research motivations.

methodsParticipants, or their caregivers, from AD treatment and prevention CTs were surveyed about research motivators.

resultsThe 87 respondents had a mean age of 72.2, were predominantly Caucasian, 55.2% were male, and 56.3% had cognitive impairment. An overwhelming majority rated the potential to help themselves or a loved one and the potential to help others in the future as important motivators. Relatively few respondents were motivated by free healthcare, monetary rewards, or to make others happy.

conclusionsRecruitment efforts should focus on the potential benefit for the individual, their loved ones, and others in the future rather than free healthcare or monetary rewards.

Indexed as

Clinical Trials as TopicMotivationPatient SelectionAlzheimer DiseaseCaregiversFemaleHumansMalePatient ParticipationResearch DesignSurveys and QuestionnairesClinical trialsMotivationRecruitment

Identifiers

PMID28523610
PMCPMC5896782
OpenAlexW2614526331

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.